Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Shares Outstanding (Diluted Average) (2023 - 2025)

Historic Shares Outstanding (Diluted Average) for Perspective Therapeutics (CATX) over the last 3 years, with Q3 2025 value amounting to $74.3 million.

  • Perspective Therapeutics' Shares Outstanding (Diluted Average) rose 519.19% to $74.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $74.3 million, marking a year-over-year increase of 519.19%. This contributed to the annual value of $64.4 million for FY2024, which is 14071.51% up from last year.
  • Perspective Therapeutics' Shares Outstanding (Diluted Average) amounted to $74.3 million in Q3 2025, which was up 519.19% from $74.2 million recorded in Q2 2025.
  • Over the past 5 years, Perspective Therapeutics' Shares Outstanding (Diluted Average) peaked at $228.6 million during Q1 2023, and registered a low of $26.8 million during Q4 2023.
  • Over the past 3 years, Perspective Therapeutics' median Shares Outstanding (Diluted Average) value was $66.6 million (recorded in 2024), while the average stood at $71.2 million.
  • Examining YoY changes over the last 5 years, Perspective Therapeutics' Shares Outstanding (Diluted Average) showed a top increase of 15175.19% in 2024 and a maximum decrease of 7834.12% in 2024.
  • Quarter analysis of 3 years shows Perspective Therapeutics' Shares Outstanding (Diluted Average) stood at $26.8 million in 2023, then surged by 140.72% to $64.4 million in 2024, then grew by 15.32% to $74.3 million in 2025.
  • Its last three reported values are $74.3 million in Q3 2025, $74.2 million for Q2 2025, and $72.4 million during Q1 2025.